150 related articles for article (PubMed ID: 32300052)
1. Hypoxia-inducible factors: new strategies for treatment of obesity-induced metabolic diseases.
Choe SS; Kim JB
Postgrad Med J; 2020 Aug; 96(1138):451-452. PubMed ID: 32300052
[No Abstract] [Full Text] [Related]
2. Inflammation, obesity, and the promise of immunotherapy for metabolic disease.
O'Rourke RW
Surg Obes Relat Dis; 2013; 9(5):609-16. PubMed ID: 22959472
[No Abstract] [Full Text] [Related]
3. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
4. Chronic tissue inflammation and metabolic disease.
Lee YS; Olefsky J
Genes Dev; 2021 Mar; 35(5-6):307-328. PubMed ID: 33649162
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue dysfunction contributes to obesity related metabolic diseases.
Blüher M
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879
[TBL] [Abstract][Full Text] [Related]
6. Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation.
Petrus P; Fernandez TL; Kwon MM; Huang JL; Lei V; Safikhan NS; Karunakaran S; O'Shannessy DJ; Zheng X; Catrina SB; Albone E; Laine J; Virtanen K; Clee SM; Kieffer TJ; Noll C; Carpentier AC; Johnson JD; Rydén M; Conway EM
EBioMedicine; 2019 Jun; 44():489-501. PubMed ID: 31221584
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic risk factors in native populations living at high altitudes.
Hirschler V
Int J Clin Pract; 2016 Feb; 70(2):113-8. PubMed ID: 26820389
[TBL] [Abstract][Full Text] [Related]
8. Persistent organic pollutants meet adipose tissue hypoxia: does cross-talk contribute to inflammation during obesity?
Myre M; Imbeault P
Obes Rev; 2014 Jan; 15(1):19-28. PubMed ID: 23998203
[TBL] [Abstract][Full Text] [Related]
9. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration.
Rausch ME; Weisberg S; Vardhana P; Tortoriello DV
Int J Obes (Lond); 2008 Mar; 32(3):451-63. PubMed ID: 17895881
[TBL] [Abstract][Full Text] [Related]
10. The initiation of metabolic inflammation in childhood obesity.
Singer K; Lumeng CN
J Clin Invest; 2017 Jan; 127(1):65-73. PubMed ID: 28045405
[TBL] [Abstract][Full Text] [Related]
11. Function and Dysfunction of Adipose Tissue.
Matafome P; Seiça R
Adv Neurobiol; 2017; 19():3-31. PubMed ID: 28933059
[TBL] [Abstract][Full Text] [Related]
12. HIF repressors under chronic hypoxia.
Luo W; Wang Y
Aging (Albany NY); 2016 Mar; 8(3):418-9. PubMed ID: 26954058
[No Abstract] [Full Text] [Related]
13. Immune cells in adipose tissue: key players in metabolic disorders.
Lolmède K; Duffaut C; Zakaroff-Girard A; Bouloumié A
Diabetes Metab; 2011 Sep; 37(4):283-90. PubMed ID: 21507694
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes.
Mimura I; Tanaka T; Wada Y; Kodama T; Nangaku M
J Pharmacol Sci; 2011; 115(4):453-8. PubMed ID: 21422728
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factors in hepatocellular carcinoma.
Chen C; Lou T
Oncotarget; 2017 Jul; 8(28):46691-46703. PubMed ID: 28493839
[TBL] [Abstract][Full Text] [Related]
16. The immunomodulating role of exercise in metabolic disease.
Lancaster GI; Febbraio MA
Trends Immunol; 2014 Jun; 35(6):262-9. PubMed ID: 24680647
[TBL] [Abstract][Full Text] [Related]
17. Adipose type I interferon signalling protects against metabolic dysfunction.
Wieser V; Adolph TE; Grander C; Grabherr F; Enrich B; Moser P; Moschen AR; Kaser S; Tilg H
Gut; 2018 Jan; 67(1):157-165. PubMed ID: 28011892
[TBL] [Abstract][Full Text] [Related]
18. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
Halligan DN; Murphy SJ; Taylor CT
Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases.
Ruiz-Ojeda FJ; Méndez-Gutiérrez A; Aguilera CM; Plaza-Díaz J
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581657
[TBL] [Abstract][Full Text] [Related]
20. Role of MAIT cells in metabolic diseases.
Toubal A; Lehuen A
Mol Immunol; 2021 Feb; 130():142-147. PubMed ID: 33358570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
